Promotions & Moves

AIT Bioscience Names New CEO

Jeff Goddard succeeds Terri Pascarelli, who has announced her retirement

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AIT Bioscience, a bioanalytical contract research organization (CRO), has appointed Jeff Goddard, MBA, as chief executive officer and member of the AIT Bioscience Board of Directors. He succeeds Terri Pascarelli, MBA. During her time as CEO, Pascarelli has led the company to significant growth, including being named on Inc. 5000’s list of fastest growing companies in both 2015 and 2017.   Pascarelli has announced her retirement and will be transitioning the leadership of the company to t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters